Efficacy and Quality of Life Data from 5-Year Follow-Up of CheckMate 214

Video

Dr Rana McKay discusses the efficacy and qualify-of-life data from the 5-year follow-up of the CheckMate 214 trial investigating nivolumab plus ipilimumab in frontline advanced renal cell carcinoma treatment.

Related Videos
Related Content